RIULSRepository of Iași University of Life Sciences, ROMANIA

Developing a Functional Osteoarthritis Model Using Human Osteochondral–Synovial Explants

Show simple item record

dc.contributor.author Lăbușcă, Luminița
dc.contributor.author Zară Dănceanu, Camelia-Mihaela
dc.contributor.author Minuti, Anca-Emanuela
dc.contributor.author Stavilă, Cristina
dc.contributor.author Petrovici, Adriana
dc.contributor.author Plămădeală, Petru
dc.contributor.author Ivanov, Iuliu
dc.contributor.author Zugun Eloae, Florin
dc.contributor.author Aniță, Dragoș-Constantin
dc.contributor.author Aniță, Adriana-Elena
dc.contributor.author Lupu, Nicoleta
dc.date.accessioned 2025-11-12T11:52:36Z
dc.date.available 2025-11-12T11:52:36Z
dc.date.issued 2025-09-23
dc.identifier.citation Luminita Labusca, Camelia-Mihaela Zara-Danceanu, Anca Emanuela Minuti, Cristina Stavila, Adriana Petrovici, Petru Plamadeala, Iuliu Ivanov, et al. 2025. “Developing a Functional Osteoarthritis Model Using Human Osteochondral–Synovial Explants.” Tissue Engineering Part A, September. https://doi.org/10.1177/19373341251377645. en_US
dc.identifier.uri https://www.liebertpub.com/doi/epdf/10.1177/19373341251377645
dc.identifier.uri https://repository.iuls.ro/xmlui/handle/20.500.12811/5903
dc.description.abstract Osteochondral explants can serve as valuable ex vivo models for investigating joint development and testing therapeutic interventions in osteoarthritis (OA). The incorporation of synovial tissue in coculture settings more closely reproduces the inflammatory milieu characteristic of OA joints; however, no report exists regarding the culture media that can support such ex vivo systems. We investigated the reactivity of osteochondral explants using two media types: Dulbecco’s modified essential medium (DMEM) and chondrogenic medium (CHONDRO). Additionally, we tested the potential therapeutic effect of serum-free conditioned media (CM) derived from allogeneic adipose-derived stem cells (ADSCs) in the context of OA. Osteochondral fragments with or without homologous synovium were cultured in DMEM and CHONDRO for up to 30 days. A subset of explants received treatment with CM. Explant reactivity was assessed by cytokine release, synovial cellularity, and osteochondral protein content usingWestern blot and immunohistochemistry. Explants kept in DMEMdisplayed diminished levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFa), together with increased Collagen II (Col II) expression. Notably, consistent suppression of TNFa was observed following CM treatment. Conversely, the CHONDRO-kept samples exhibited an increased prevalence of chondrocyte clusters; heightened Perlecan presence as well as IL-1b levels in response to CMtreatment and synovial tissue-dependent fluctuations in Col II levels. Remarkably, significantly increased b-galactosidase levels could be detected in osteochondral tissues treated with CM, regardless of the culturemedia type. In the experimental conditions created, DMEMprovided a neutral milieu and was less prone to confounding experimental outcomes, rendering it suitable for evaluating potential therapies. CHONDRO apparently increased chondrocyte clusters and facilitated extracellular matrix synthesis; however, its usage requires caution due to potential interference with experimental readouts. CM could exert an antisenescence effect, an effect that warrants further investigation. en_US
dc.language.iso en en_US
dc.publisher Mary Ann Liebert en_US
dc.rights CC BY 4.0
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject precision medicine en_US
dc.subject immunohistochemistry en_US
dc.subject osteoarthritis en_US
dc.subject explant models en_US
dc.subject synovial tissue en_US
dc.subject western blot en_US
dc.subject conditioned media en_US
dc.title Developing a Functional Osteoarthritis Model Using Human Osteochondral–Synovial Explants en_US
dc.type Article en_US
dc.author.affiliation Luminita Labusca, Camelia-Mihaela Zara-Danceanu, Anca Emanuela Minuti,1, Cristina Stavila, * Petru Plamadeala,7 Iuliu Ivanov,3 Florin Zugun-Eloae,3 Dragos Anita,5,6,† Adriana Anita,5,6,† and Nicoleta Lupu1
dc.author.affiliation Luminita Labusca
dc.author.affiliation Camelia-Mihaela Zara-Danceanu,
dc.author.affiliation Cristina Stavila
dc.author.affiliation Adriana Petrovici,
dc.author.affiliation Adriana Petrovici,
dc.publicationName Tissue Engineering Part A
dc.volume pre-print
dc.issue
dc.publicationDate 2025
dc.identifier.eissn 1937-335X
dc.identifier.doi https://doi.org/10.1177/19373341251377645


Files in this item

This item appears in the following Collection(s)

Show simple item record

CC BY 4.0 Except where otherwise noted, this item's license is described as CC BY 4.0